Comparison of the Treatment Efficacy of Rituximab and Plasmapheresis/Intravenous Immunoglobulin Combination with Historical Control in Chronic Antibody Mediated Rejection

Ruhi, Caglar; Tugcu, MURAT; Kasapoglu, Umut; Gokce, Ali; ATA, PINAR; Titiz, Mesut

doi:10.5262/tndt.2017.1001.08

Comparison of the Treatment Efficacy of Rituximab and Plasmapheresis/Intravenous Immunoglobulin Combination with Historical Control in Chronic Antibody Mediated Rejection

Atıf İçin Kopyala

Ruhi C., Tugcu M., Kasapoglu U., Gokce A. M., ATA P., Titiz M. I.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, cilt.26, sa.1, ss.48-54, 2017 (ESCI)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 26 Sayı: 1
Basım Tarihi: 2017
Doi Numarası: 10.5262/tndt.2017.1001.08
Dergi Adı: TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.48-54
Marmara Üniversitesi Adresli: Evet

Özet

OBJECTIVE: Chronic antibody mediated rejection (CAMR) is a major therapeutic challenge for achieving long-term graft survival; treatment options are limited to several anti-humoral interventions.